J&J Seeks Fed. Circ. Rehearing On Stent Patents
By Abigail Rubenstein ( July 27, 2011, 1:45 PM EDT) -- Johnson & Johnson asked the Federal Circuit last week to rehear its appeal of a decision in favor of Boston Scientific Corp. that deemed four J&J patents for drug-eluting stents invalid for lack of adequate written description....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.